ArticleAsian journal of andrology

Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Jeanny B Aragon-ChingPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.